Search for: "SHIRE V SANDOZ"
Results 1 - 20
of 39
Sorted by Relevance
|
Sort by Date
28 Jan 2015, 10:00 pm
On January 26, 2015, the Supreme Court granted certiorari, vacated, and remanded Shire Development LLC v. [read post]
9 Apr 2014, 9:59 pm
The problems with the current jurisprudential situation regarding claim construction are nicely illustrated by the Court's decision in Shire Development, LLC v. [read post]
15 Jan 2012, 8:27 pm
Shire LLC et al. v. [read post]
4 Jun 2015, 2:03 am
Sandoz in affirming ED Texas in Fenner v. [read post]
9 Dec 2008, 10:23 am
Shire LLC v. [read post]
26 Jan 2015, 10:37 am
Butamax, and Shire v. [read post]
3 Jun 2015, 9:23 pm
Shire v. [read post]
6 May 2007, 9:06 pm
Teva Carbatrol: Shire v. [read post]
2 Apr 2007, 9:52 pm
Glenmark Pending Cases Updated: Adderall XR: Shire v. [read post]
17 May 2021, 12:45 am
On the 20th of August 2013 AstraZeneca served the decision on Sandoz, thereby forcing Sandoz off the market. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed - US: Monsanto files patent infringement suit based on defendant's use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed – US: Monsanto files patent infringement suit based on defendant’s use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
18 Nov 2009, 4:57 am
Sandoz Inc (Patent Docs) Roundup Ready soybean seed - US: Monsanto files patent infringement suit based on defendant's use of seed produced from earlier planted Roundup Ready soybean seed: Monsanto Co. et al. v. [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
27 Sep 2008, 12:08 am
(Biotech Blog) United States: Patent for generating oxygen in a process that mimics photosynthesis (Competitive info) Products Adderall (Dextroamphetamine/Racemic DL-ampthetamine) - US: Judge denies Sandoz’ bid for summary judgment of non infringement in patent dispute with Shir eover Adderall (Law360) Carbatrol (Carbamazepine) - US: Judge refuses to grant summary judgment to Corepharma in patent dispute with Shire Laboratories over generic Carbatrol… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
14 Jul 2010, 6:47 pm
(Patent Docs) NovoNorm (Repaglinide) – France: Tribunal de Grande Instance: Claims 2 and 3 invalid for lack of novelty: Hexal and Sandoz v. [read post]
10 Jun 2010, 3:58 am
(SmartBrief) Emend (Aprepitant) - US: Sandoz counterclaims for two patents dismissed in Merck’s Emend suit (Patent Docs) Intuniv (Guanfacine) – US: Patent infringement complaint based on ANDA filing: Shire LLC et al. v. [read post]
19 Jan 2011, 2:00 am
– Health Care Reform Bill (Patent Baristas) US: Academic study supports longer data exclusivity term for conventional drugs (Patent Docs) US: PTO sued after denying ‘mildly tardy’ second interim PTE request: Genetics & IVF Institute v Kappos (FDA Law Blog) US: AMP v USPTO – Appellees’ brief (Patent Docs) Products Avodart (Dutasteride) – US: GlaxoSmithKline file patent infringement complaint against Anchen following Para IV certification… [read post]
